Clinical Context
A typical patient is a 58-year-old ambulatory adult with symptomatic osteoarthritis of the knee presenting to an orthopedic clinic after conservative measures (physical therapy, oral NSAIDs, weight loss, and activity modification) provided insufficient pain relief. The clinician confirms focal tibiofemoral joint pain with exam and radiographs consistent with moderate osteoarthritis. After shared decision-making, the clinician schedules an intra-articular viscosupplementation injection using J7329 (Hyaluronan or derivative, TriVisc, 1 mg). On the day of service the patient registers at an outpatient ambulatory surgical center or office-based procedure suite. Vital signs and an allergy check are performed; informed consent specific to intra-articular hyaluronan injection is obtained and documented. The procedural workflow includes aseptic skin preparation, optional local anesthetic, ultrasound or landmark-guided intra-articular needle placement, aspiration if effusion present, and administration of the J7329 product. Post-procedure monitoring for 10–30 minutes evaluates immediate adverse reactions. Documentation includes indication, laterality (LT or RT modifier when applicable), product name and NDC or lot number, dose, number of injections, procedural details, and post-procedure instructions. Typical sites of service are the outpatient office, ambulatory surgical center, or hospital outpatient department. Common payors covering this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.